MMP14 and glioblastoma: That would help design individualized clinical trials to tease out the full effects of MMP inhibition since it has been shown that combination therapy of MMP-14 inhibitor with chemotherapy prolonged survival of GBM patients while Marimastat alone had no benefit in recurrent GBM 42.